Pereira-Oliveira, M.; Reis-Mendes, A.; Carvalho, F.; Remião, F.; Bastos, M.d.L.; Costa, V.M.
Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells. Biomolecules 2019, 9, 21.
https://doi.org/10.3390/biom9010021
AMA Style
Pereira-Oliveira M, Reis-Mendes A, Carvalho F, Remião F, Bastos MdL, Costa VM.
Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells. Biomolecules. 2019; 9(1):21.
https://doi.org/10.3390/biom9010021
Chicago/Turabian Style
Pereira-Oliveira, Maria, Ana Reis-Mendes, Félix Carvalho, Fernando Remião, Maria de Lourdes Bastos, and Vera Marisa Costa.
2019. "Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells" Biomolecules 9, no. 1: 21.
https://doi.org/10.3390/biom9010021
APA Style
Pereira-Oliveira, M., Reis-Mendes, A., Carvalho, F., Remião, F., Bastos, M. d. L., & Costa, V. M.
(2019). Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells. Biomolecules, 9(1), 21.
https://doi.org/10.3390/biom9010021